A space for sharing and discussing news related to global current events, technology, and society.
69640 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69640 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
70.1
0
70.1
The Novavax Covid-19 vaccine could be cleared by regulators for use in multiple countries, including the U.S., in the coming months, the vaccine-maker’s CEO said Monday.
The Novavax Covid-19 vaccine could be cleared by regulators for use in multiple countries, including the U.S., in the coming months, the vaccine-maker’s CEO said Monday.
The vaccine could be in high demand. Novavax’s vaccine is protein based, using an alternative technology to the more widespread mRNA vaccines. Skeptics leery of the mRNA technology may be inclined to get the Novavax version, Erck said, which also has been seen to present fewer adverse side effects than other vaccines.
The vaccine could be in high demand. Novavax’s vaccine is protein based, using an alternative technology to the more widespread mRNA vaccines. Skeptics leery of the mRNA technology may be inclined to get the Novavax version, Erck said, which also has been seen to present fewer adverse side effects than other vaccines.
Some low-ranking comments may have been hidden.
Some low-ranking comments may have been hidden.